Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 12:06 AM
NCT ID:
NCT04452058
Eligibility Criteria:
Inclusion Criteria:
* (a) that were pathologically confirmed as precancerous lesions or Stage I lung adenocarcinoma （≤3cm）
* (b) standard Chest CT scans with or without contrast enhancement performed \<3 months before surgery；
* (c) availability of clinical characteristics.
Exclusion Criteria:
* (a) preoperative therapy (neoadjuvant chemotherapy or radiotherapy) performed,
* (b) suffering from other tumor disease before or at the same time.
* (c) Contain other pathological components such as squamous cell lung carcinoma (SCC) or small cell lung carcinoma (SCLC) or
* (d) poor image quality.
Inclusion Criteria of immunotherapy cohort:
* (a) that were diagnosed as advanced NSCLC
* (b) Both standard Chest CT scans with contrast enhancement performed \<3 months before and after first dose of immunotherapy are available；
* (c) availability of clinical characteristics.
Exclusion Criteria of immunotherapy cohort:
* (a) Ever receiving pulmonary operation on the same side of the lesion.
* (b) suffering from other tumor disease before or at the same time.
* (c) Contain other pathological components( SCLC or lymphoma) or
* (d) poor image quality.
* (e) incomplete clinical data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04452058
Study Brief:
Protocol Section:
NCT04452058